|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Accretion of discount on convertible notes | |||||
| Depreciation and amortization of property and equipment | |||||
| Amortization of finance lease right of use asset | |||||
| Impairment of acquired intangible asset | |||||
| Impairment of operating lease right-of-use asset | |||||
| Write down of property and equipment, net | |||||
| Stock-based compensation | |||||
| Accretion of discount on investments, net | |||||
| Expense in connection with warrant issuance | |||||
| Change in fair value of warrant liabilities | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and accrued expenses | |||||
| Operating lease liabilities and right of use assets, net | |||||
| Finance lease liability | |||||
| Other liabilities | |||||
| Net cash used in operating activities | |||||
| Investing activities: | |||||
| Purchases of investments | |||||
| Proceeds from maturities of investments | |||||
| Cash proceeds from acquisition of business, net of cash paid | |||||
| Payments made to acquire right of use asset | |||||
| Purchases of property and equipment | |||||
| Net cash provided by investing activities | |||||
| Financing activities: | |||||
| Issuance of common stock, net of issuance costs | |||||
| Public Offering | |||||
| At-the-Market Offering | |||||
| Issuance of common stock pursuant to exercise of stock options | |||||
| Treasury stock repurchase | |||||
| Issuance of common stock, pursuant to sale of treasury stock | |||||
| Issuance of common stock, pursuant to exercise of warrants | |||||
| Return of related party short-swing profits | |||||
| Repurchase of restricted stock units to satisfy tax withholding | |||||
| Net cash provided by financing activities | |||||
| Net change in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
| Supplemental disclosure of non-cash financing and investing activities: | |||||
| Accrued purchases of property and equipment, ending balance | |||||
| Receivables from sale of property and equipment, ending balance | |||||
| Operating lease liabilities | |||||
| Operating lease right of use assets | |||||
| Net unrealized loss on investments | |||||
| Conversion of convertible notes into common stock | |||||
| Issuance of common stock related to acquisition | |||||
| Reclassification of construction in process from finance right of use asset | |||||
| Supplemental cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
Loading...